Last year, Taltz rang up sales of $937.5 million, and doctors are increasingly prescribing it. For the first six months of this year, Taltz recorded $606.3 million in sales, putting it on pace to break the $1 billion threshold, perhaps in the third quarter.
Read More
The purchase would swell Elanco from the world’s fourth-largest animal health player to the second-largest, behind only New Jersey-based Zoetis.
Read More
The multibillion-dollar deal would swell the size of Elanco, which already is the fourth-largest global player in animal health.
Read More
Carroll uses Twitter, a New York Times column, blog post, podcast, videos and books to publish his findings on just about any health issue he thinks needs explaining or correcting.
Read More
The device, manufactured in Singapore, won a Mira Award earlier this year for Innovation of the Year, and now its creator said he’s winning over doctors and medical providers with his invention.
The state says it is investigating 30 cases of severe lung injury linked to vaping. Eight have been confirmed—most of them among individuals between the ages of 16 and 29.
The state, which ranks third worst in the nation in maternal mortality, said it will use the money to develop ways to prevent or manage maternal illness.
Money will go toward such uses as collecting more timely data on overdoses treated at emergency rooms and enhancing the state’s prescription-monitoring program.
The company’s rapid rise to the top of the multi-billion-dollar U.S. e-cigarette market has been accompanied by accusations from parents, politicians and public health advocates that Juul fueled a vaping craze among high schoolers.
The formulas would take into account several factors, including opioid distribution in a given jurisdiction, the number of people who misuse opioids and the number of overdose deaths.
The dispute centers on extensive cracking in the foundation at Community Hospital East, which just underwent a massive, $175 million upgrade with a new patient tower.
Robert Wilkie, secretary of veterans affairs, told the American Legion National Convention in Indianapolis on Wednesday that the issue needs urgent attention.
While the price of almost any good or service can be found online, most Americans don’t know what they’ll owe for a prescription medication until they get it.
Drugmaker Purdue Pharma is negotiating a multibillion-dollar settlement with lawyers for local and state governments that would resolve about 2,000 lawsuits against the company.
Indiana accounted for 4% of the nation’s opioid-related deaths, but received just 1.9% of the nation’s $11 billion opioid-related funding awarded to states over the past two years, according to the new study.
The landmark decision is the first to hold a drugmaker culpable for the fallout of years of liberal opioid dispensing that began in the late 1990s, sparking a nationwide epidemic of overdose deaths and addiction.
The lawsuit, filed in U.S. District Court in Indianapolis, is the first such federal lawsuit in the state against Juul, a company battling numerous complaints over its products.
More than 100 nursing aides, activities coordinators, cooks and other workers at two Indianapolis senior communities could lose their jobs by mid-October when the properties are sold, owner Justus Rental Properties Inc. said.
The facility would be built on about six acres of undeveloped land off East 126th Street, east of Hoosier Road.
Indiana has one of the highest smoking rates in the country—nearly one in five Hoosiers smoke. Now, a new statewide policy makes it easier for smokers to get medication to help them quit. But some people want state leaders to do more.
Investors appeared to be nervous over the rich price of the deal and the amount of debt that Elanco will take on to finance it.
After years of frequent list price hikes, many drugmakers are showing some restraint, according to the analysis of drug prices.
The clinics are designed to treat patients quickly for such things are earaches, nose bleeds, twisted ankles and rashes, eliminating the need to go to a busy emergency room or wait several days to see a primary care doctor.
President Donald Trump’s plan to import cheap Canadian drugs overlooks a crucial fact: Canada’s pharmaceutical supply chain is beholden to the drugmakers.